Skip to content

Targeting of UnControlled Hypertension in Emergency Department

Targeting of UnControlled Hypertension in Emergency Department (TOUCHED)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03749499
Acronym
TOUCHED
Enrollment
574
Registered
2018-11-21
Start date
2019-02-19
Completion date
2023-03-31
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Hypertension, Vascular Diseases

Keywords

Emergency Department, Minorities

Brief summary

The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagement and early risk assessment/stratification is a cost-effective, feasible innovation to help close health disparity gaps in HTN. This proposal involves a two-arm randomized controlled trial of up to 770 patients from the Emergency Department at University of Illinois Hospital with elevated blood pressure (BP). The primary objective is to determine the effectiveness of an emergency department-initiated Educational and Empowerment (E2) intervention with a Post Acute Care Hypertension Consultation (PACHT-c) intervention (arm 2) on the primary outcome of mean systolic blood pressure (SBP) differences between the two trial arms at 6-months post intervention. Secondary objectives include evaluating the effectiveness of this ED education and empowerment intervention on mean SBP and diastolic blood pressure (DBP) differences at 3-months, and mean DBP differences at 6-months.

Detailed description

The study is a single-site randomized controlled trial (RCT) focused on a high-risk ED population with evidence of moderately elevated BP (≥140/90 mmHg) at discharge. ED patients will be recruited and randomized into two arms: 1) usual care (preprinted discharge instructions and 48-72 hour referral to a federally qualified health center (FQHC) or assigned provider as appropriate); 2) ED-initiated E2 intervention program followed by 48-72 hour referral to a FQHC (or assigned health center). Based on the ED population demographics (70% ethnic minorities), the majority of participants will be underrepresented minorities (NHB and Hispanic) and low-income individuals. The investigators propose the following specific aims and hypotheses: Aim 1: Evaluate the effectiveness of an ED-based E2 + PACHT-c intervention (arm 2) on the primary outcome of mean SBP difference at 6-months post-intervention compared to usual care (arm 1). H1: The mean SBP difference (from baseline) will be significantly greater in the E2+ PACHT-c group (arm 2) compared to the usual care group (arm 1) at 6- months post-randomization, i.e., SBP change in arm 2 \> arm 1 at 6-months post-randomization. Aim 2: Evaluate the effectiveness of an ED-based E2 intervention with PACHT-c on the secondary outcome of mean SBP and DBP differences at 3-months, and mean DBP differences at 6 months post-intervention compared to usual care. H2: The mean SBP and DBP differences from baseline to 3- months post-intervention and mean DBP at 6-months post intervention will be significantly greater in the ED-based E2 intervention compared to the usual care group, i.e., SBP and DBP change in arm 2 \> arm 1 at 3 -months post-intervention and DBP change in arm 2 \> arm 1 at 6 -months post-intervention.

Interventions

OTHERHTN Educational Video

The video will educate participants in arm 2 about high BP, how it is diagnosed, and the importance of treating it to prevent secondary complications.

OTHERVisual Echocardiogram Image Clips

Visual clips of age/gender-matched echocardiograms will be used to educate and motivate patients to change their behavior and improve their BP. We have found that real time visualization of cardiac ultrasound images with active discussion of findings is a significant patient motivator and empowerment tool, and was a significant factor in the success of our previous pilot study.

OTHERMobile Health and Remote BP monitoring

All participants randomized to the intervention group will receive an FDA-approved HBPM kit that includes the Nokia wireless (self-inflating) BPM+ monitor and Health Mate mobile app. The app automatically launches when the patient slips on the cuff and turns on the monitor to measure his/her BP. Synced data are automatically uploaded from the mobile app to the iCardia server of our study.

OTHERPost-Acute Care HTN Transition consultation (PACHT-c)

All participants randomized to the E2 intervention will have a focused consultation with either a clinical pharmacist or an APN. During this consultation, the pharmacist/APN repeats the BP measurement; reviews the screening assessments; and reviews general principles of BP control including nutrition, exercise, and smoking cessation. BP will be managed according to the current published guidelines available at the time of funding regarding initiation of first-line antihypertensive medications. Patients with BP ≥160/100 mmHg may be started on antihypertensive medications by the provider during the consultation if appropriate.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Outcomes Assessor)

Masking description

Research Assistants are blinded to study arm assignment of participant when assessing outcomes measures.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* BP\>=140/90 and \<=180/110 mm Hg at time of discharge from ED * Verbal fluency in English or Spanish * Age 18-75 years

Exclusion criteria

* Unable to verbalize comprehension of study, impaired decision-making or documented dementia * Plans to move from Chicago area within the next year * Pregnant or trying to get pregnant * COVID-19 positive within the past 14 days

Design outcomes

Primary

MeasureTime frameDescription
Mean Systolic Blood Pressure (SBP) Difference at 6 Months Post-intervention Compared to Usual Care.Baseline, 6 months after baselineBlood pressure will be collected at two time points (baseline and 6 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Secondary

MeasureTime frameDescription
Mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.Baseline, 3 months after baselineBlood pressure will be collected at two time points (baseline and 3 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.
Diastolic Blood Pressure (DBP) Difference at 6 Months Post-intervention Compared to Usual Care.Baseline, 6 months after baselineBlood pressure will be collected at two time points (baseline and 6 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Countries

United States

Participant flow

Participants by arm

ArmCount
Usual Care
Participants randomized to usual care will receive preprinted discharge instructions on HTN and a 48-72-hour referral to our FQHC (or other community health center if pre-assigned though Illinois Medicaid) to schedule their follow-up appointment (current standard of care)
285
Educational and Empowerment Intervention
Participants receive: 1. HTN Educational Video about high BP, how it is diagnosed, and importance of treatment to prevent secondary complications. 2. Visual Echocardiogram Image Clips of age/gender-matched echocardiograms will be used to educate and motivate patients to change behavior and improve their BP. 3. Mobile Health and Remote BP monitoring- participants receive an FDA-approved home blood pressure monitoring (HBPM) kit that includes the monitor and Health Mate mobile app. The app automatically launches when the patient slips on the cuff. Synced data are automatically uploaded from the mobile app to the iCardia server of our study. 4. A Post-Acute Care HTN Transition consultation (PACHT-c) with a clinical pharmacist or advanced practice nurse (APN). Post-Acute Care HTN Transition consultation (PACHT-c): All participants randomized to the E2 intervention will have a focused consultation with either a clinical pharmacist or an APN. During this consultation, the pharmacist/APN repeats the BP measurement; reviews the screening assessments; and reviews general principles of BP control including nutrition, exercise, and smoking cessation. BP will be managed according to the current published guidelines available at the time of funding regarding initiation of first-line antihypertensive medications. Patients with BP ≥160/100 mmHg may be started on antihypertensive medications by the provider during the consultation if appropriate.
289
Total574

Baseline characteristics

CharacteristicUsual CareEducational and Empowerment InterventionTotal
Age, Continuous51.9 years
STANDARD_DEVIATION 13
50.3 years
STANDARD_DEVIATION 11.9
51.1 years
STANDARD_DEVIATION 12.5
Insurance
Medicare/Medicaid
149 Participants135 Participants284 Participants
Insurance
Other
7 Participants8 Participants15 Participants
Insurance
Private
69 Participants85 Participants154 Participants
Insurance
Unknown/Missing
60 Participants61 Participants121 Participants
Race/Ethnicity, Customized
Black
204 Participants209 Participants413 Participants
Race/Ethnicity, Customized
Hispanic/Latino
56 Participants59 Participants115 Participants
Race/Ethnicity, Customized
Other
8 Participants11 Participants19 Participants
Race/Ethnicity, Customized
White
17 Participants10 Participants27 Participants
Sex: Female, Male
Female
162 Participants161 Participants323 Participants
Sex: Female, Male
Male
123 Participants128 Participants251 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
7 / 2850 / 289
other
Total, other adverse events
0 / 2850 / 289
serious
Total, serious adverse events
0 / 2850 / 289

Outcome results

Primary

Mean Systolic Blood Pressure (SBP) Difference at 6 Months Post-intervention Compared to Usual Care.

Blood pressure will be collected at two time points (baseline and 6 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Time frame: Baseline, 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
Usual CareMean Systolic Blood Pressure (SBP) Difference at 6 Months Post-intervention Compared to Usual Care.-9.2 mmHgStandard Deviation 24.4
Educational and Empowerment InterventionMean Systolic Blood Pressure (SBP) Difference at 6 Months Post-intervention Compared to Usual Care.-14.0 mmHgStandard Deviation 19.3
Secondary

Diastolic Blood Pressure (DBP) Difference at 6 Months Post-intervention Compared to Usual Care.

Blood pressure will be collected at two time points (baseline and 6 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Time frame: Baseline, 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
Usual CareDiastolic Blood Pressure (DBP) Difference at 6 Months Post-intervention Compared to Usual Care.-1.3 mmHgStandard Deviation 14.5
Educational and Empowerment InterventionDiastolic Blood Pressure (DBP) Difference at 6 Months Post-intervention Compared to Usual Care.-3.3 mmHgStandard Deviation 12.1
Secondary

Mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.

Blood pressure will be collected at two time points (baseline and 3 months). ED-pharmacists and trained research assistants will perform BP measurements using standardized procedures.

Time frame: Baseline, 3 months after baseline

ArmMeasureGroupValue (MEAN)Dispersion
Usual CareMean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.SBP-9.8 mmHgStandard Deviation 22.5
Usual CareMean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.DBP-1.5 mmHgStandard Deviation 13.4
Educational and Empowerment InterventionMean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.SBP-14 mmHgStandard Deviation 20.5
Educational and Empowerment InterventionMean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Differences at 3 Months Post-intervention Compared to Usual Care.DBP-2.4 mmHgStandard Deviation 11.7

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026